Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 5
1994 7
1995 1
1996 5
1997 1
1998 5
1999 7
2000 8
2001 9
2002 4
2003 5
2004 6
2005 15
2006 23
2007 3
2008 11
2009 12
2010 8
2011 18
2012 15
2013 27
2014 18
2015 29
2016 18
2017 16
2018 25
2019 14
2020 26
2021 19
2022 19
2023 13
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

359 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial.
Kaasch AJ, López-Cortés LE, Rodríguez-Baño J, Cisneros JM, Dolores Navarro M, Fätkenheuer G, Jung N, Rieg S, Lepeule R, Coutte L, Bernard L, Lemaignen A, Kösters K, MacKenzie CR, Soriano A, Hagel S, Fantin B, Lafaurie M, Talarmin JP, Dinh A, Guimard T, Boutoille D, Welte T, Reuter S, Kluytmans J, Martin ML, Forestier E, Stocker H, Vitrat V, Tattevin P, Rommerskirchen A, Noret M, Adams A, Kern WV, Hellmich M, Seifert H; SABATO study group. Kaasch AJ, et al. Among authors: kern wv. Lancet Infect Dis. 2024 May;24(5):523-534. doi: 10.1016/S1473-3099(23)00756-9. Epub 2024 Jan 17. Lancet Infect Dis. 2024. PMID: 38244557 Clinical Trial.
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.
Thompson GR 3rd, Soriano A, Cornely OA, Kullberg BJ, Kollef M, Vazquez J, Honore PM, Bassetti M, Pullman J, Chayakulkeeree M, Poromanski I, Dignani C, Das AF, Sandison T, Pappas PG; ReSTORE trial investigators. Thompson GR 3rd, et al. Lancet. 2023 Jan 7;401(10370):49-59. doi: 10.1016/S0140-6736(22)02324-8. Epub 2022 Nov 25. Lancet. 2023. PMID: 36442484 Free article. Clinical Trial.
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Herbrecht R, et al. Among authors: kern wv. N Engl J Med. 2002 Aug 8;347(6):408-15. doi: 10.1056/NEJMoa020191. N Engl J Med. 2002. PMID: 12167683 Free article. Clinical Trial.
Bacterial bloodstream infection.
Allerberger F, Kern WV. Allerberger F, et al. Among authors: kern wv. Clin Microbiol Infect. 2020 Feb;26(2):140-141. doi: 10.1016/j.cmi.2019.10.004. Epub 2019 Oct 12. Clin Microbiol Infect. 2020. PMID: 31614195 Free article. No abstract available.
Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study.
Kuehl R, Morata L, Boeing C, Subirana I, Seifert H, Rieg S, Kern WV, Kim HB, Kim ES, Liao CH, Tilley R, Lopez-Cortés LE, Llewelyn MJ, Fowler VG, Thwaites G, Cisneros JM, Scarborough M, Nsutebu E, Gurgui Ferrer M, Pérez JL, Barlow G, Hopkins S, Ternavasio-de la Vega HG, Török ME, Wilson P, Kaasch AJ, Soriano A; International Staphylococcus aureus collaboration study group and the ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis. Kuehl R, et al. Among authors: kern wv. Lancet Infect Dis. 2020 Dec;20(12):1409-1417. doi: 10.1016/S1473-3099(20)30447-3. Epub 2020 Aug 4. Lancet Infect Dis. 2020. PMID: 32763194
[Vaccinations].
Pletz MW, Zanger P, Jilg W, Kern WV. Pletz MW, et al. Among authors: kern wv. Dtsch Med Wochenschr. 2011 Oct;136(40):2011-5. doi: 10.1055/s-0031-1286382. Epub 2011 Sep 28. Dtsch Med Wochenschr. 2011. PMID: 21960329 Review. German. No abstract available.
[Steroids in infection medicine].
Spinner CD, Barton J, Biever P, Klein M, Rieg S, Schneider J, Thoden J, Wagner D, Kern WV. Spinner CD, et al. Among authors: kern wv. Dtsch Med Wochenschr. 2021 Feb;146(3):162-166. doi: 10.1055/a-1302-3530. Epub 2021 Jan 29. Dtsch Med Wochenschr. 2021. PMID: 33513649 Review. German.
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.
Averbuch D, Orasch C, Cordonnier C, Livermore DM, Mikulska M, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, Akova M; ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN. Averbuch D, et al. Among authors: kern wv. Haematologica. 2013 Dec;98(12):1826-35. doi: 10.3324/haematol.2013.091025. Haematologica. 2013. PMID: 24323983 Free PMC article.
HIV Gene Therapy: An Update.
Cornu TI, Mussolino C, Müller MC, Wehr C, Kern WV, Cathomen T. Cornu TI, et al. Among authors: kern wv. Hum Gene Ther. 2021 Jan;32(1-2):52-65. doi: 10.1089/hum.2020.159. Hum Gene Ther. 2021. PMID: 33349126 Review.
359 results